Dr. Peter Altman and Mr. David McClung, CEO and CFO of BioCardia, respectively, will also be participating in one-on-one meetings with investors at both conferences. If you are an institutional or ...
An updated corporate presentation will also be available at . About Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat ...
Newly listed Bone Biologics Corporation (NASDAQ: BBLG) shares are surging after the Company announced to present at the H.C. Wainwright BioConnect Virtual Conference. Bone Biologics is focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results